EUCTR2005-000963-25-GB进行中（未招募）1 期
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil in the Treatment of Subjects Who Have Completed Study A1481131 - N/A
Pfizer Limited, Ramsgate Road, Sandwich, Kent, UK0 个研究点目标入组 234 人开始时间: 2006年9月19日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 234
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •· Pediatric subjects, who enrolled in and completed Study A1481131;
- •· Females of childbearing potential who are sexually active must be practicing a suitable method of birth control so that in the opinion of the investigator, they will not become pregnant during the study; and
- •· The investigator must obtain written informed consent and assent where applicable before the subject is considered for enrollment in Study A1481156. The inclusion of a subject more than once in the same clinical trial is not permissible.
- •All inclusion criteria must be adhered to.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Pediatric subjects, who did not complete Study A1481131.
- •Subjects with known hereditary degenerative retinal disorders (such as retinitis
- •pigmentosa) or history of non-arteritic anterior ischemic optic neuropathy (NAION).
- •The exclusion criteria must be adhered to.
研究者
相似试验
进行中（未招募）
不适用
Oral Revatio in Pediatric PAH - Long-term follow-on Study to A1481131.MedDRA version: 14.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersPulmonary Arterial HypertensionEUCTR2005-000963-25-Outside-EU/EEAPfizer Limited, Ramsgate Road, Sandwich, Kent, UK220
进行中（未招募）
不适用
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil in the Treatment of Subjects Who Have Completed Study A1481131 - N/APulmonary Arterial HypertensionEUCTR2005-000963-25-FIPfizer Limited, Ramsgate Road, Sandwich, Kent, UK185
进行中（未招募）
1 期
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil in the Treatment of Subjects Who Have Completed Study A1481131 - N/AMedDRA version: 8.1Level: LLTClassification code 10064911Pulmonary Arterial HypertensionEUCTR2005-000963-25-SKPfizer Limited, Ramsgate Road, Sandwich, Kent, UK185
进行中（未招募）
不适用
Oral Revatio in Pediatric PAH- Long term follow on study to A1481131Pulmonary Arterial HypertensionMedDRA version: 14.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2005-000963-25-SEPfizer Limited, Ramsgate Road, Sandwich, Kent, UK200
已完成
3 期
ong-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) (contRAst X)Rheumatoid ArthritisJPRN-jRCT2080225238GlaxoSmithKline K.K.2,640